• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 中的免疫反应复杂性。

Complexity of immune responses in COVID-19.

机构信息

Biosciences Institute, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK; Department of Otolaryngology, Freeman Hospital, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, NE7 7DN, UK.

Biosciences Institute, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK; Haematology Department, Freeman Hospital, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, NE7 7DN, UK.

出版信息

Semin Immunol. 2021 Jun;55:101545. doi: 10.1016/j.smim.2021.101545. Epub 2021 Nov 27.

DOI:10.1016/j.smim.2021.101545
PMID:34865933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8626289/
Abstract

The global COVID-19 pandemic has caused substantial morbidity and mortality to humanity. Remarkable progress has been made in understanding both the innate and adaptive mechanisms involved in the host response to the causative SARS-CoV-2 virus, but much remains to be discovered. Robust upper airway defenses are critical in restricting SARS-CoV-2 replication and propagation. Further, the nasal abundance of viral uptake receptor, ACE2, and the host epithelial transcriptional landscape, are associated with differential disease outcomes across different patient cohorts. The adaptive host response to systemic COVID-19 is heterogeneous and complex. Blunted responses to interferon and robust cytokine generation are hallmarks of the disease, particularly at the advanced stages. Excessive immune cell influx into tissues can lead to substantial collateral damage to the host akin to sepsis. This review offers a contemporary summary of these mechanisms of disease and highlights potential avenues for diagnostic and therapeutic development. These include improved disease stratification, targeting effectors of immune-mediated tissue damage, and blunting of immune cell-mediated tissue damage.

摘要

全球 COVID-19 大流行给人类带来了巨大的发病率和死亡率。在理解宿主对致病 SARS-CoV-2 病毒的固有和适应性反应机制方面已经取得了显著进展,但仍有许多有待发现。强大的上呼吸道防御对于限制 SARS-CoV-2 的复制和传播至关重要。此外,鼻内病毒摄取受体 ACE2 的丰度和宿主上皮细胞转录景观与不同患者群体的不同疾病结局相关。宿主对全身 COVID-19 的适应性反应是异质和复杂的。干扰素反应迟钝和细胞因子生成旺盛是该疾病的特征,特别是在晚期阶段。免疫细胞大量涌入组织会导致宿主的大量附带损伤,类似于败血症。本文综述了这些疾病发生机制,并强调了潜在的诊断和治疗发展途径。这些途径包括改善疾病分层、针对免疫介导的组织损伤效应物以及抑制免疫细胞介导的组织损伤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ae/8626289/11b50ea0e9bd/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ae/8626289/632377467b79/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ae/8626289/11b50ea0e9bd/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ae/8626289/632377467b79/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ae/8626289/11b50ea0e9bd/gr2_lrg.jpg

相似文献

1
Complexity of immune responses in COVID-19.COVID-19 中的免疫反应复杂性。
Semin Immunol. 2021 Jun;55:101545. doi: 10.1016/j.smim.2021.101545. Epub 2021 Nov 27.
2
Mechanistic understanding of innate and adaptive immune responses in SARS-CoV-2 infection.SARS-CoV-2 感染中固有和适应性免疫反应的机制理解。
Mol Immunol. 2021 Jul;135:268-275. doi: 10.1016/j.molimm.2021.04.021. Epub 2021 Apr 30.
3
Human Nasal and Lung Tissues Infected with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper and Lower Respiratory Tract.人鼻腔和肺部组织感染 SARS-CoV-2 提供了在上呼吸道和下呼吸道中不同组织特异性和病毒特异性先天免疫反应的见解。
J Virol. 2021 Jun 24;95(14):e0013021. doi: 10.1128/JVI.00130-21.
4
Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2.COVID-19 中的免疫反应:通过靶向 SARS-CoV-2 触发的途径来应对药理学挑战。
Signal Transduct Target Ther. 2020 May 29;5(1):84. doi: 10.1038/s41392-020-0191-1.
5
Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.SARS-CoV-2 感染的免疫学方面及维生素-D 的可能有益作用。
Int J Mol Sci. 2021 May 16;22(10):5251. doi: 10.3390/ijms22105251.
6
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.I型、II型和III型干扰素的抗病毒活性可抵消ACE2的诱导性并限制新型冠状病毒。
mBio. 2020 Sep 10;11(5):e01928-20. doi: 10.1128/mBio.01928-20.
7
Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.利用免疫系统克服 COVID-19 中的细胞因子风暴并降低病毒载量:疾病各阶段和治疗药物综述。
Virol J. 2020 Oct 15;17(1):154. doi: 10.1186/s12985-020-01415-w.
8
SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.SARS-CoV-2 大流行和研究空白:了解 SARS-CoV-2 与 ACE2 受体的相互作用及其对治疗的影响。
Theranostics. 2020 Jun 12;10(16):7448-7464. doi: 10.7150/thno.48076. eCollection 2020.
9
Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.新型冠状病毒病 2019 与哮喘、变应性鼻炎:分子机制与宿主-环境相互作用。
Curr Opin Allergy Clin Immunol. 2021 Feb 1;21(1):1-7. doi: 10.1097/ACI.0000000000000699.
10
Gut microbiome, Vitamin D, ACE2 interactions are critical factors in immune-senescence and inflammaging: key for vaccine response and severity of COVID-19 infection.肠道微生物组、维生素 D、ACE2 相互作用是免疫衰老和炎症老化的关键因素:对疫苗反应和 COVID-19 感染严重程度至关重要。
Inflamm Res. 2022 Jan;71(1):13-26. doi: 10.1007/s00011-021-01510-w. Epub 2021 Nov 5.

引用本文的文献

1
μSARS2 Chip: A Peptide-Based Microarray to Assess COVID-19 Prognosis Based on Immunological Fingerprints.μSARS2芯片:一种基于肽的微阵列,用于基于免疫指纹评估新冠肺炎预后。
ACS Pharmacol Transl Sci. 2025 Feb 21;8(3):871-884. doi: 10.1021/acsptsci.4c00727. eCollection 2025 Mar 14.
2
Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD: Insights from a Single-Center Prospective Cohort Study.探讨 MAFLD 患者应用 Paxlovid 的疗效:一项单中心前瞻性队列研究的启示。
Viruses. 2024 Jan 12;16(1):112. doi: 10.3390/v16010112.
3
COVID-19 on Oral Health: A New Bilateral Connection for the Pandemic.

本文引用的文献

1
Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2.I 型和 III 型干扰素的延迟诱导介导了鼻腔上皮细胞对 SARS-CoV-2 的易感性。
Nat Commun. 2021 Dec 7;12(1):7092. doi: 10.1038/s41467-021-27318-0.
2
Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury.新冠病毒肺炎患者血浆中某些细胞因子水平升高反映了病毒载量和肺损伤。
Natl Sci Rev. 2020 Jun;7(6):1003-1011. doi: 10.1093/nsr/nwaa037. Epub 2020 Mar 9.
3
Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona.
新冠疫情对口腔健康的影响:大流行中的一种新的双向关联
Biomedicines. 2023 Dec 26;12(1):60. doi: 10.3390/biomedicines12010060.
4
Therapeutic plasma exchange in the treatment of COVID-19 induced cytokine storm: the first Moroccan experience.治疗性血浆置换治疗 COVID-19 诱导的细胞因子风暴:摩洛哥的首次经验。
BMC Infect Dis. 2023 Nov 25;23(1):829. doi: 10.1186/s12879-023-08816-6.
5
TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD-A Prospective Case-Control Study.转化生长因子β作为非酒精性脂肪性肝病患者新冠病毒疾病严重程度的预后生物标志物——一项前瞻性病例对照研究
Microorganisms. 2023 Jun 13;11(6):1571. doi: 10.3390/microorganisms11061571.
6
Role of Saliva as a Non-Invasive Diagnostic Method for Detection of COVID-19.唾液作为检测新冠病毒的非侵入性诊断方法的作用。
Cureus. 2022 Jul 29;14(7):e27471. doi: 10.7759/cureus.27471. eCollection 2022 Jul.
7
Cytokine Storm Signature in Patients with Moderate and Severe COVID-19.中度和重度 COVID-19 患者的细胞因子风暴特征。
Int J Mol Sci. 2022 Aug 10;23(16):8879. doi: 10.3390/ijms23168879.
8
Distinct Cytokine Profiles in Severe COVID-19 and Non-Alcoholic Fatty Liver Disease.重症 COVID-19 与非酒精性脂肪性肝病中不同的细胞因子谱
Life (Basel). 2022 May 26;12(6):795. doi: 10.3390/life12060795.
9
Combinatorial analysis reveals highly coordinated early-stage immune reactions that predict later antiviral immunity in mild COVID-19 patients.组合分析揭示了高度协调的早期免疫反应,这些反应可预测轻症 COVID-19 患者后期的抗病毒免疫。
Cell Rep Med. 2022 Mar 29;3(4):100600. doi: 10.1016/j.xcrm.2022.100600. eCollection 2022 Apr 19.
巴塞罗那 ICU 收治的 COVID-19 患者中,近 10% 患者预先存在中和高浓度 I 型干扰素的自身抗体。
J Clin Immunol. 2021 Nov;41(8):1733-1744. doi: 10.1007/s10875-021-01136-x. Epub 2021 Sep 27.
4
Autoantibodies neutralizing type I IFNs are present in 4% of uninfected individuals over 70 years old and account for 20% of COVID-19 deaths.在 70 岁以上未感染的人群中,有 4%存在中和 I 型干扰素的自身抗体,占 COVID-19 死亡人数的 20%。
Sci Immunol. 2021 Aug 19;6(62). doi: 10.1126/sciimmunol.abl4340.
5
SARS-CoV-2 (COVID-19), viral load and clinical outcomes; lessons learned one year into the pandemic: A systematic review.严重急性呼吸综合征冠状病毒2(COVID-19)、病毒载量与临床结局;大流行一年来的经验教训:一项系统综述
World J Crit Care Med. 2021 Jul 9;10(4):132-150. doi: 10.5492/wjccm.v10.i4.132.
6
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.德尔塔变异株对抗体中和的敏感性降低。
Nature. 2021 Aug;596(7871):276-280. doi: 10.1038/s41586-021-03777-9. Epub 2021 Jul 8.
7
Impact of SARS-CoV-2 variants on the total CD4 and CD8 T cell reactivity in infected or vaccinated individuals.新冠病毒变异株对感染或接种个体中总 CD4 和 CD8 T 细胞反应性的影响。
Cell Rep Med. 2021 Jul 20;2(7):100355. doi: 10.1016/j.xcrm.2021.100355. Epub 2021 Jul 2.
8
Intravenous methylprednisolone with or without tocilizumab in patients with severe COVID-19 pneumonia requiring oxygen support: A prospective comparison.静脉注射甲基强的松龙联合或不联合托珠单抗治疗需要吸氧支持的重症 COVID-19 肺炎患者:一项前瞻性比较。
J Infect Public Health. 2021 Aug;14(8):985-989. doi: 10.1016/j.jiph.2021.06.003. Epub 2021 Jun 10.
9
ColdZyme Maintains Integrity in SARS-CoV-2-Infected Airway Epithelia.冷酶在感染 SARS-CoV-2 的气道上皮中保持完整性。
mBio. 2021 Apr 27;12(2):e00904-21. doi: 10.1128/mBio.00904-21.
10
Single-cell multi-omics analysis of the immune response in COVID-19.单细胞多组学分析 COVID-19 中的免疫反应。
Nat Med. 2021 May;27(5):904-916. doi: 10.1038/s41591-021-01329-2. Epub 2021 Apr 20.